Uncovering the pharmacological response of novel sesquiterpene derivatives that differentially alter gene expression and modulate the cell cycle in cancer cells

Abstract

The present study aimed to assess the pharmacological anticancer profile of three natural and five synthetic sesquiterpenes developed by total chemical synthesis. To this end, their properties at the cellular and molecular level were evaluated in a panel of normal and cancer cell lines. The results obtained by performing cytotoxicity assays and gene expression analysis by reverse transcription-quantitative polymerase chain reaction showed that: i) Among the sesquiterpene derivatives analyzed, VDS58 exhibited a notable anticancer profile within attached (U-87 MG and MCF-7) and suspension (K562 and MEL-745) cancer cell cultures; however, U-87 MG cells were able to recover their proliferation capacity rapidly after 48 h of exposure; ii) gene expression profiling of U-87 MG cells, in contrast to K562 cells, showed a transient induction of cyclin-dependent kinase inhibitor 1A (CDKN1) expression; iii) the expression levels of transforming growth factor β1 (TGFB1) increased after 12 h of exposure of U-87 MG cells to VDS58 and were maintained at this level throughout the treatment period; iv) in K562 cells exposed to VDS58, TGFB1 expression levels were upregulated for 48 h and decrease afterwards; and v) the re-addition of VDS58 in U-87 MG cultures pretreated with VDS58 resulted in a notable increase in the expression of caspases (CASP3 and CASP9), BCL2‑associated agonist of cell death (BAD), cyclin D1, CDK6, CDKN1, MYC proto-oncogene bHLH transcription factor (MYC), TGFB1 and tumor suppressor protein p53. This upregulation persisted only for 24 h for the majority of genes, as afterwards, only the expression of TGFB1 and MYC was maintained at high levels. Through bioinformatic pathway analysis of RNA-Seq data of parental U-87 MG and K562 cells, substantial variation was reported in the expression profiles of the genes involved in the regulation of the cell cycle. This was associated with the differential pharmacological profiles observed in the same cells exposed to VDS58. Overall, the data presented in this study provide novel insights into the molecular mechanisms of action of sesquiterpene derivatives by dysregulating the expression levels of genes associated with the cell cycle of cancer cells.

Novel Thiazolidin-4-ones as Potential Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase

“…Cell growth in each treated culture is expressed as a percentage compared to that seen for the untreated control cells. Moreover, cell death was also determined using the Trypan-blue method, as previously described [51,52]. Statistical t-test analysis was performed via the use of GraphPad Prism 6.0 program.…”

4-(Indol-3-yl)thiazole-2-amines and 4-ιndol-3-yl)thiazole Acylamines as Νovel Antimicrobial Agents: Synthesis, In Silico and In Vitro Evaluation

“…Note that the concentration of DMSO in culture was ≤ 0.2% v/v, in which no detectable effect on cell proliferation was observed (1). The evaluation of cytotoxicity of each compound and the measure of the number of dead cells was described previously [44,67,68].…”

“…The established human fibroblast-derived MRC-5 normal cell line was chosen to be applied in this work in order to test the cytotoxicity of the new synthesized chemical molecules since its application has been licensed by regulatory bodies for human vaccine production and new drug development [65,66]. To this end, it is reasonable for MRC-5 to be used to develop new antimicrobial and antiviral agents, as well as anticancer therapeutics, in order to evaluate its selectivity in cytotoxicity for bacteria, virus, and malignant cells opposite to normal human cells, as previously published [44,67,68].…”

Analysis of TCGA data of differentially expressed EMT‑related genes and miRNAs across various malignancies to identify potential biomarkers

“…The established cell lines of human breast epithelial carcinoma MCF-7 (Cellosaurus, CVCL-0031) and MDA-MB-231 (Cellosaurus, CVCL-0062), as well as the human tongue squamous carcinoma HSC-3 (Cellosaurus, CVCL-1288) and keratinocyte HaCaT (Cellosaurus, CVCL-0038) cancer cells that are routinely used in the authors' laboratory were cultured as previously described (19,20). Moreover, the RNA isolation, RT-cDNA synthesis, as well as the RT-qPCR analysis were carried out as previously described (19,20). In brief, total RNA was extracted from cells using TRItidY G (Panreac, Applichem), quantified using a Nanodrop ND-100 Spectrometer and reverse transcribed into cDNA by applying the QuantiTect Reverse Transcription kit (Qiagen, Inc.).…”